Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0317558 CONJUGATES OF A PHOSPHOLIPID AND A DRUG FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
Conjugates of drugs suitable for use in the treatment of inflammatory bowel disease and phospholipids, and their use in the treatment of inflammatory bowel...
2016/0317557 A PHARMACEUTICAL COMPOSITION CONTAINING COMBINATIONS OF NICOTINAMIDE AND 5-AMINOSALICYLIC ACID FOR BENEFICIALLY...
The present invention relates to a new pharmaceutical composition containing a combination of 5-aminosalicylic acid and nicotinamide or related compounds. The...
2016/0317556 ATP SYNTHASE INHIBITORS AND STEROID ALKALOIDS AND USES THEREOF AS ANTIMICROBIAL AGENTS AND AS POTENTIATORS FOR...
The present invention provides bacterial ATP synthase inhibitors such as a compound of formula (I): (Formula (I)) (A) in combination with an aminoglycoside...
2016/0317555 METHOD FOR ON-DEMAND CONTRACEPTION
The invention relates to a method for on-demand contraception, which method comprises administering a progestogen agent or progesterone receptor modulator,...
2016/0317554 Antihistamines In Combination With A Range Of Substances For Improved Health
The present invention provides for novel combinations comprising an antihistamine with selected pharmaceutical and nutraceutical agents which alleviate some of...
2016/0317553 ORAL PHARMACEUTICAL PRODUCTS AND METHODS OF USE COMBINING TESTOSTERONE ESTERS WITH HYPOLIPIDEMIC AGENTS
Pharmaceutical products comprising a hypolipidemic agent and a testosterone ester such as testosterone undecanoate are provided. Methods of safely treating a...
2016/0317552 PHARMACEUTICAL FORMULATIONS FOR TREATING MALE SEXUAL DYSFUNCTIONS
Pharmaceutical compositions and methods for treating various male sexual dysfunction disorders, such as erectile dysfunction or Peyronie's disease, are...
2016/0317551 Treating Basal-Like Genotype Cancers
Provided herein are methods of treating a subject with cancer comprising administering to the subject a death receptor agonist. Also provided herein are...
2016/0317550 METHODS FOR FAT REDUCTION
Disclosed herein are methods, compounds, and compositions for fat reduction, and in particular fat reduction without significant hair growth and/or additional...
2016/0317549 PLATINUM COMPOUNDS, COMPOSITIONS, AND USES THEREOF
The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum (IV) complex...
2016/0317548 Methods for Treating Epithelian Mesenchymal Transition Related Diseases
Certain embodiments are directed to methods of treating chronic lung diseases in a subject comprising administering to a subject diagnosed with, exhibiting...
2016/0317547 Male Contraceptive Compositions And Methods Of Use
The invention relates to compositions and methods for effecting male contraception.
2016/0317546 METHOD FOR TREATING OTIC INFECTIONS AFTER TYMPANOSTOMY TUBE PLACEMENT
The present invention relates to methods for treating a microbial infection comprising administering a composition comprising one or more antibiotic compounds...
2016/0317545 SUBSTITUTED ANILINES AS CCR(4) ANTAGONISTS
Aniline compounds are provided which bind to CCR(4) and are useful for the treatment of diseases such as allergic diseases, autoimmune diseases, graft...
2016/0317544 USE OF NON-PEPTIDE NK1 ANTAGONISTS IN A PREDETERMINED DOSE FOR THE TREATMENT OF CANCER
Use of the non-peptide NK1 receptor antagonist, preferably Aprepitant, for the treatment of cancer in predetermined doses. The present invention also describes...
2016/0317543 SPIROCYCLIC HETERCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS
The present invention relates to Spirocyclic Heterocycle Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, B, X, Y, R.sup.1,...
2016/0317542 PDE5 INHIBITOR POWDER FORMULATIONS AND METHODS RELATING THERETO
Novel dry powder compositions comprising and methods relating thereto are provided. The dry powder compositions comprise PDE5 inhibitors, such as vardenafil,...
2016/0317541 PROPHYLACTIC AGENT AND/OR THERAPEUTIC AGENT FOR DIFFUSE LARGE B-CELL LYMPHOMA
To provide a medicament which shows more remarkable effect in treatment of activated B-cell like diffuse large B-cell lymphoma (ABC-CLBCL) than the existing...
2016/0317540 Therapeutic Treatment
The present invention relates to a combination comprising (S)-4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo[2,3-d]py- ...
2016/0317539 PHARMACEUTICAL COMPOSITION NOT CONTAINING ANTIOXIDANT AND PREPARATION METHOD THEREFOR
Provided are a composition containing an unstable drug against oxidation like pemetrexed with improved stability and a preparation method thereof, by removing...
2016/0317538 CANCER TREATMENTS USING COMBINATIONS OF CDK AND ERK INHIBITORS
The present invention provides, inter alia, methods, kits, and pharmaceutical compositions for treating or ameliorating the effects of a cancer in a subject in...
2016/0317537 NOVEL COMPOUNDS
Compounds of formula (I): ##STR00001## are described herein. Compounds of the disclosure are modulators of Kv3 channels and may be used in the prophylaxis or...
2016/0317536 MNK INHIBITORS AND METHODS RELATED THERETO
The present invention relates to compounds according to Formula (I): ##STR00001## or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, ...
2016/0317535 METHOD OF PREVENTING OR TREATING SKIN NECROPTOSIS DISEASE COMPRISING RIP3-MLKL PATHWAY BLOCKER
The present invention relates to methods of preventing or treating skin necroptosis diseases, including administering to subjects receptor-interacting protein...
2016/0317534 FREEZE DRIED DRUG NANOSUSPENSIONS
The present invention relates to a freeze-dried (also called lyophilized) drug nanosuspension. The present freeze-dried drug nanosuspension composition has an...
2016/0317533 SUBSTITUTED QUINOXALINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR4
The present invention relates to the use of novel quinoxaline derivatives of formula (I) ##STR00001## as positive allosteric modulators for modulating...
2016/0317532 COMPOUNDS USEFUL AS MODULATORS OF TRPM8
The present invention includes compounds useful as modulators of TRPM8, such as compounds of Formula (I) and the subgenus and species thereof; personal...
2016/0317531 RIBONUCLEOTIDE REDUCTASE INHIBITORS SENSITIZE TUMOR CELLS TO DNA DAMAGING AGENTS
The present invention relates to methods for treatment of tumors comprising administering to a subject in need thereof a DNA damaging agent and a...
2016/0317530 ABUSE-RESISTANT DRUG FORMULATIONS
Disclosed are abuse resistant oral pharmaceutical compositions that reduce the likelihood of improper administration of drugs that are susceptible to abuse....
2016/0317529 4-(8-METHOXY-1-((1-METHOXYPROPAN-2-YL)-2-(TETRAHYDRO-2H-PYRAN-4-YL)-1 ...
Novel quinoline compounds pharmaceutical compositions containing such compounds and their use in therapy.
2016/0317528 COMBINED AGENT FOR CELL THERAPY OF CORNEAL ENDOTHELIAL CELL
The present invention provides an agent for treating or preventing a disease, a disorder or a condition of a corneal endothelium, said agent comprising a...
2016/0317527 TETRAHYDRONAPHTHYRIDINYL PROPIONIC ACID DERIVATIVES AND USES THEREOF
The present application relates to use of compounds of formula I for treating or preventing a fibrosis.
2016/0317526 PROLYLHYDROXYLASE/ATF4 INHIBITORS AND METHODS OF USE FOR TREATING NEURAL CELL INJURY OR DEATH AND CONDITIONS...
Methods for treating a patient suffering from neural cell injury, the method comprising administering to the patient an effective amount of a HIF...
2016/0317525 TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND TERIFLUNOMIDE
This invention provides a method of treating a subject afflicted with multiple sclerosis (MS) or presenting a clinically isolated syndrome (CIS) comprising...
2016/0317524 PHARMACEUTICAL COMPOSITION CONTAINING PALONOSETRON
Provided are a pharmaceutical composition with improved stability including palonosetron, a preparation method thereof, and a pharmaceutical package including...
2016/0317523 Treatment of Retinopathy of Prematurity (ROP)
Disclosed herein are methods of treating retinopathy of prematurity (ROP) in a premature and/or low birth weight infant in need thereof, comprising ...
2016/0317522 INHALABLE SUSTAINED THERAPEUTIC FORMULATIONS
The present invention is based, in part, on the unexpected discovery that particles for pulmonary delivery of a therapeutic, prophylactic or diagnostic agent...
2016/0317521 REDUCING MEMORY LOSS IN MAMMALS SUFFERING FROM ALZHEIMER'S DISEASE
The disclosure relates to methods and compositions for reducing memory loss. Specifically, methods of using inhibitors of GAT-3 polypeptide activity to reduce...
2016/0317520 ANIMAL PEST CONTROL METHOD
Disclosed is a method for protecting an animal from a parasitic invertebrate pest comprising treating an animal orally or by injection with a pesticidally...
2016/0317519 METHODS AND COMPOSITIONS FOR TREATING NON-ERK MAPK PATHWAY INHIBITOR-RESISTANT CANCERS
The present invention provides, inter alia, methods, pharmaceutical compositions, and kits for treating or ameliorating the effects of a cancer in a subject,...
2016/0317518 COMPOSITION FOR REDUCING SENESCENCE OF CELL OR SUBJECT INCLUDING BRAF INHIBITOR AND USE THEREOF
Provided is a method of reducing senescence in a cell or subject, or treating or preventing a symptom or disease associated therewith, by administering a BRAF...
2016/0317517 CANCER TREATMENTS USING COMBINATIONS OF PI3K/AKT PATHWAY AND ERK INHIBITORS
The present invention provides, inter alia, methods, kits, and compositions for treating or ameliorating the effects of a cancer in a subject in need thereof....
2016/0317516 RAC1 INHIBITORS OF NEUROFIBROMA FORMATION
Small molecule inhibitor compounds for inhibiting Rac1 activity and their use for treating, preventing, or reducing the incidences of malignant and ...
2016/0317515 Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological Procedures
Compositions of a cyclooxygenase inhibitor and a calcium channel antagonist in a liquid carrier. The composition may be administered the urinary tract during...
2016/0317514 USE OF EP4 RECEPTOR ANTAGONISTS IN THE TREATMENT OF CARTILAGE DISEASE
This invention relates to a compound with EP4 antagonistic activity, or a pharmaceutically acceptable salt with EP4 receptor antagonistic activities, which is...
2016/0317513 ANTI-INFLAMMATORY COMPOUNDS
Compositions comprising isolated ido-BR1 are described for use in therapy or prophylaxis, including the treatment of inflammatory diseases (for example as...
2016/0317512 PYRIDYLAMINOACETIC ACID COMPOUND AND POLYOXYETHYLENE CASTOR OIL-CONTAINING PHARMACEUTICAL COMPOSITION
The purpose of the present invention is to provide: a pharmaceutical composition that comprises the pyridylaminoacetic acid compound of the present invention,...
2016/0317511 BENZAMIDES AND RELATED INHIBITORS OF FACTOR XA
Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against...
2016/0317510 METHODS OF USING (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OX- ...
Methods of treating, preventing or managing cancers are disclosed. The methods encompass the administration of SNS-595 in combination with a second active...
2016/0317509 MLK INHIBITORS AND METHODS OF USE
Provided are compounds having an inhibitory effect on Mixed Lineage Kinases. Also provided are pharmaceutical compositions, methods of preparing the compounds,...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.